The drug-shock strategy was more effective for patients experiencing atrial fibrillation for the first time and for patients younger than 70 years, the researchers said. Both the anti-arrhythmia drug ...
Nicholas P. Gall, M.Sc., M.D., M.R.C.P.; Francis D. Murgatroyd, M.A., F.R.C.P., F.A.C.C. From these and subsequent studies, it became clear that cardioversion was ...
A heart shock may restore the heart’s rhythm and is a potential treatment for atrial fibrillation (AFib). Doctors also refer to heart shock as electrical cardioversion. In AFib, a person has an ...
Patients with atrial fibrillation (AF) who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban - a ...
Medtronic alerted healthcare professionals in Europe to the risk of cardioversion-related damage to the Vanta implantable neurostimulator (INS), model 977006, During cardioversion, healthcare workers ...
PRINCETON, N.J. & NEW YORK--Bristol-Myers Squibb Company and Pfizer Inc. today announced that the first patient has been enrolled into a Phase IV clinical trial called EMANATE (Eliquis evaluated in ...
A small series provides provocative new data on the safety of performing direct current cardioversion (DCCV) without oral anticoagulation in high-risk patients with a Watchman left atrial appendage ...
Medtronic has warned that one of the models in its Vanta range of implantable neurostimulators for pain relief may stop working if the patient is given cardioversion therapy to restore a normal heart ...
I recently diagnosed atrial fibrillation in a 24-year-old man with new-onset chest pain, irregular palpitations, and heart rate >170 beats per minute. The patient has no history of drug or tobacco ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results